Leonie Bluhm

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

Lisa Zimmer, Julia Vaübel, Peter Mohr et al. · PLoS ONE · 2015 · 291 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Jürgen C. Becker, Selma Ugurel, Ulrike Leiter et al. · The Lancet · 2023 · 70 citations

Medicine, Immunology, Oncology +16

Pre‐analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients

Svenja Schneegans, Lelia Lück, Katharina Besler et al. · Molecular Oncology · 2020 · 32 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition

Sarah Knispel, Maximilian Gassenmaier, Alexander M. Menzies et al. · European Journal of Cancer · 2021 · 32 citations

Life Sciences, Immunology, Oncology +17

Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG

Cindy Franklin, Peter J. Mohr, Leonie Bluhm et al. · Journal for ImmunoTherapy of Cancer · 2022 · 19 citations · Full text

Medicine, Oncology, Radiation Oncology +17